Extract

The purpose of this study is to determine the treatment effect of Panitumumab in combination with chemotherapy versus chemotherapy alone as first line therapy for metastatic and/or recurrent squamous cell carcinoma of the head and neck.

Inclusion criteria

• Recurrent and/or Metastatic Head and Neck Cancer

Links

• ictrp
• nct